NO174105C - Analogifremgangsmåte for fremstilling av antikoagulerende peptider - Google Patents

Analogifremgangsmåte for fremstilling av antikoagulerende peptider

Info

Publication number
NO174105C
NO174105C NO880268A NO880268A NO174105C NO 174105 C NO174105 C NO 174105C NO 880268 A NO880268 A NO 880268A NO 880268 A NO880268 A NO 880268A NO 174105 C NO174105 C NO 174105C
Authority
NO
Norway
Prior art keywords
preparation
analogous process
anticoagulant peptides
anticoagulant
peptides
Prior art date
Application number
NO880268A
Other languages
English (en)
Other versions
NO174105B (no
NO880268D0 (no
NO880268L (no
Inventor
John L Krstenansky
Simon J T Mao
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO880268D0 publication Critical patent/NO880268D0/no
Publication of NO880268L publication Critical patent/NO880268L/no
Publication of NO174105B publication Critical patent/NO174105B/no
Publication of NO174105C publication Critical patent/NO174105C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO880268A 1987-01-23 1988-01-22 Analogifremgangsmåte for fremstilling av antikoagulerende peptider NO174105C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US641787A 1987-01-23 1987-01-23
US5316287A 1987-05-21 1987-05-21

Publications (4)

Publication Number Publication Date
NO880268D0 NO880268D0 (no) 1988-01-22
NO880268L NO880268L (no) 1988-07-25
NO174105B NO174105B (no) 1993-12-06
NO174105C true NO174105C (no) 1994-03-16

Family

ID=26675603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880268A NO174105C (no) 1987-01-23 1988-01-22 Analogifremgangsmåte for fremstilling av antikoagulerende peptider

Country Status (19)

Country Link
EP (1) EP0276014B1 (no)
JP (1) JP2709817B2 (no)
KR (1) KR960014105B1 (no)
CN (1) CN88100260A (no)
AR (1) AR245140A1 (no)
AT (1) ATE110743T1 (no)
AU (1) AU601801B2 (no)
CA (1) CA1341032C (no)
DE (1) DE3851238T2 (no)
DK (1) DK173757B1 (no)
ES (1) ES2063740T3 (no)
FI (1) FI89060C (no)
HU (1) HU199159B (no)
IE (1) IE63547B1 (no)
IL (1) IL85159A (no)
NO (1) NO174105C (no)
NZ (1) NZ223236A (no)
PH (1) PH26263A (no)
PT (1) PT86600B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
WO1990006128A1 (en) * 1988-12-05 1990-06-14 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
ZA899247B (en) * 1988-12-07 1990-09-26 Merrell Dow Pharma Anticoagulant peptides
US5232912A (en) * 1988-12-07 1993-08-03 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
ZA907742B (en) * 1989-10-03 1991-07-31 Merrell Dow Pharma Anticoagulant peptides
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
ZA907743B (en) * 1989-10-03 1991-07-31 Merrell Dow Pharma Radiolabeled anticoagulant peptides
CA2035917C (en) * 1990-02-13 2001-10-02 John L. Krstenansky Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4005591A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Die blutgerinnung inhibierende peptide, verfahren zu ihrer herstellung und ihre verwendung
US6060451A (en) * 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
WO1992001710A1 (en) * 1990-07-24 1992-02-06 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
AU640502B2 (en) * 1990-07-24 1993-08-26 Merrell Dow Pharmaceuticals Inc. Analogs of hirudin having antiplatelet activity
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
DE4103649A1 (de) * 1991-02-07 1992-08-13 Basf Ag Neue antikoagulatorisch wirksame peptide
DE69213628T2 (de) * 1991-03-05 1997-04-24 Fuji Yakuhin Kogyo Kk Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz
US5767235A (en) * 1991-03-05 1998-06-16 Nippon Mining Company Limited Anticoagulant hirudin variants and methods for their production
IT1250689B (it) * 1991-07-22 1995-04-21 Marco Gerna Analoghi dell'irudina e procedimento per la loro preparazione
CA2114223A1 (fr) * 1991-07-31 1993-02-18 Denise Mattei Polypeptides aptes a induire in vivo des anticorps eux-memes capables d'inhiber l'invasion de globules rouges par des merozoites de p. falciparum, produits apparentes et leur application a la production de compositions vaccinantes
ES2199963T3 (es) * 1993-06-11 2004-03-01 Merrell Pharmaceuticals Inc. Peptidos trifuncionales antitrombina y antiplaquetarios.
GB9426038D0 (en) 1994-12-22 1995-02-22 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
US6057314A (en) * 1995-12-21 2000-05-02 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
US5831003A (en) * 1996-06-28 1998-11-03 Bayer Corporation Peptides which bind to prothrombin and thrombin
GB0209249D0 (en) * 2002-04-23 2002-06-05 Evolutec Ltd Anticoagulants
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
CN102757479B (zh) * 2012-05-09 2014-04-30 北京林业大学 高活性降血压肽及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.

Also Published As

Publication number Publication date
EP0276014A3 (en) 1990-05-16
DK31088D0 (da) 1988-01-22
PH26263A (en) 1992-04-01
PT86600A (pt) 1988-02-01
NZ223236A (en) 1989-11-28
HUT46339A (en) 1988-10-28
JPS63215698A (ja) 1988-09-08
NO174105B (no) 1993-12-06
CN88100260A (zh) 1988-11-09
AU601801B2 (en) 1990-09-20
IL85159A (en) 1993-04-04
IL85159A0 (en) 1988-06-30
NO880268D0 (no) 1988-01-22
IE880167L (en) 1988-07-23
ES2063740T3 (es) 1995-01-16
FI880286A0 (fi) 1988-01-22
DE3851238T2 (de) 1995-03-16
CA1341032C (en) 2000-06-20
FI880286A (fi) 1988-07-24
EP0276014A2 (en) 1988-07-27
AR245140A1 (es) 1993-12-30
ATE110743T1 (de) 1994-09-15
IE63547B1 (en) 1995-05-17
DE3851238D1 (de) 1994-10-06
DK173757B1 (da) 2001-09-10
DK31088A (da) 1988-07-24
KR960014105B1 (ko) 1996-10-14
HU199159B (en) 1990-01-29
EP0276014B1 (en) 1994-08-31
NO880268L (no) 1988-07-25
FI89060B (fi) 1993-04-30
FI89060C (fi) 1993-08-10
AU1072988A (en) 1988-07-28
JP2709817B2 (ja) 1998-02-04
KR880009045A (ko) 1988-09-13
PT86600B (pt) 1991-12-31

Similar Documents

Publication Publication Date Title
NO174105C (no) Analogifremgangsmåte for fremstilling av antikoagulerende peptider
FI981380A (fi) Menetelmä HCV-polypeptidien valmistamiseksi
NO180362C (no) Fremgangsmåte for fremstilling av cyklosporinholdige preparater
PT86875A (pt) Process for the preparation of phenylcarbamate
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
NO176922C (no) Fremgangsmåte for fremstilling av bifunksjonelle proteiner
HU890720D0 (en) Process for the preparation of protein-like water-dispersingable macrocolloides
NO173498C (no) Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner
FI891074A (fi) Menetelmä syklisten sulfaattien valmistamiseksi
NO171734C (no) Fremgangsmaate for fremstilling av kornorienterte, magnetostriktive legemer
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
FI881303A (fi) Menetelmä ibuprofeenin valmistamiseksi
NO174424C (no) Fremgangsmåte for fremstilling av dinatrium-cefodizim
FI872769A0 (fi) Menetelmä alfa-mono-olefiinien polymeroimiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
DK549688D0 (da) Fremstilling af peptider
PT86091A (en) Process for the preparation of novel peptides
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
FI885045A (fi) Menetelmä polynukleotidien valmistamiseksi
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
PT87732A (pt) Process for the preparation of (e)-(p-fluorophenethyl)-3-fluoroallylamine
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI903604A0 (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
PT85033A (en) Process for the preparation of novel peptides
FR2599038B1 (fr) Procede de preparation de nonacosapeptides et peptides intermediaires